Noa Laguna-Goya

Spanish Ministry of Economy, Industry and Competitiveness (Madrid)

Noa Laguna-Goya works for the Spanish Ministry of the Economy.

Linked authors

DG COMP (Brussels)
DG COMP (Brussels)
DG COMP (Brussels)
DG COMP (Brussels)


507 Bulletin

Marion Bailly, Noa Laguna-Goya, Rositsa Pencheva The EU Commission clears the acquisition of a pharmaceutical company by a global conglomerate subject to commitment that clinical development of innovative insomnia drugs will not be adversely affected by the merger (Johnson & Johnson / Actelion)


J&J/Actelion - falling asleep fast and deeply while staying fully awake on innovation * In a nutshell: The Commission found competitive concerns due to the combination of two development programmes for insomnia drugs, currently in Phase II of clinical trials. These pipeline drugs are based (...)

Arthur Stril, Ivan Gasperec, Marion Bailly, Noa Laguna-Goya The EU Commission clears acquisition of fourth largest global manufacturer of generic medicines by the largest global competitor, subject to complex remedies and monitoring, including addressing concerns about vertical relationships between parties for the first time in a generics merger (Teva / Allergan Generics)


Teva/Allergan Generics: An unprecedented generics merger* In a nutshell While the Commission has had significant experience dealing with mergers in the generic medicines industry, the sheer scale of Teva/Allergan Generics, combining two of the top four players globally, posed a number of (...)